Western PharmacoEconomics and Outcomes Research Conference

Date: 04/02/21
Meeting Type: Zoom

8:30am-8:45am Welcome and Opening Remarks – Diana Brixner, RPh, PhD, FAMCP
8:45am-9:30am Session I – "Reflections on the Success of Pharmacoeconomics: Will It Prepare US for the Future? ""

Diana Brixner, RPh, PhD, FAMCP

Professor, Department of Pharmacotherapy, University of Utah

Keynote Speaker:
Michael Drummond, PhD
Professor, Centre for Health Economics, University of York

9:30am-10:15am Panel: "How to Pay for Expensive Therapies – What Evidence Do We Need?""

Joseph Biskupiak, PhD, MBA

University of Utah

1. Ron Akehurst, BSc (Econ)(London), DSc, Hon MFPH
Chairman of BresMed and Professor Emeritus, University of Sheffield in the School of Health and Related Research (ScHARR)

2. Daniel Malone, RPh, PhD, FAMCP
Professor, Department of Pharmacotherapy, University of Utah

10:15am - 10:25am Break
10:25am - 11:45am Podium Presentation - Session I – (20 min each)

Karen Rascati, PhD

10:25am-10:45am- Jagadeswara Rao Earla
University of Houston, TX
"Effect Of Different Inverse Probability Treatment Weights (Iptw) On Adherence Trajectories Between Oral Fingolimod And Injectable Disease Modifying Agents Inmultiple Sclerosis"

10:45am-11:05am- Katia Hannah
Universtiy of Colorado
"Eliciting Patient Preferences for Continuous Glucose Monitoring Devices in Type 1 Diabetes"

11:05am-11:25am- Alex Watanabe
Universtiy of Utah
"Development and Analysis of a Novel Digital Health App Designed for Cystic Fibrosis"

11:25am-11:45pm- Samuel Crawford
University of Southern California
"Estimating The Value Of Nursing Time To Reduce Costs And Increase Quality Of Pressure Injury Prevention In Nursing Homes: A Cost-Effectiveness Analysis Of The “Team-Up” Clinical Trial "

11:45am-12:15pm Lunch
12:15pm-1:15pm Podium Presentation - Session II – (20 min each)

Beth Devine, PharmD, PhD, Professor
The CHOICE Institute

12:55pm-12:35pm- Vanessa Paul Patterson
University of Colorado Anschutz Medical Campus
"Cost-Effectiveness Analysis Of Pembrolizumab Monotherapy Versus Platinum-Based Chemotherapy For First-Line Treatment Of Programmed Death Ligand-1 Expressing, Locally Advanced Non-Small-Cell Lung Cancer In The United States"

12:35pm-12:55pm- Tingting Qu
BresMed America Inc
"Review And Comparison Of Overall Survival Extrapolation In Health Technology Assessments For Chimeric Antigen Receptor T-Cell Therapies(Car-Ts)""

12:55pm-1:15pm- Eunice Kim
University of Washigton
Elements of Value for Gene Therapy: A Systematic Review
1:15pm - 1:20pm Break
1:20pm - 2:05pm Session II
"Biosimilars in the US: the current state of affairs, barriers to utilization, and real-world research efforts to support treatment and coverage decisions"

Brett McQueen, PhD

Assistant Professor, University of Colorado

Cate Lockhart, PharmD, PhD

Executive Director, Biologics and Biosimilars Collective Intelligence Consortium
2:15pm-3:35pm Session III - Poster Session with Authors & Refreshments – virtually
Room #1: Moderator: Dan Malone
Room #2: Moderator: Diana Brixner
Room #3: Moderator: Joe Biskupiak
Room #4: Moderator: Nathorn Chaiyakunapruk
3:35pm - 3:45pm Break

3:45pm - 4:45pm

Session IV - Career Panel
Moderator: Lou Garrison
Danny Yeh, PhD (Genentech)
Casey Tak, PhD, MPH (University of North Carolina)
Doug Burgoyne, PharmD (Biologics & Biosimilars Collective Intelligence Consortium (AMCP)

4:45pm - 5:00pm
Closing Remarks - Diana Brixner, RPh, PhD, FAMCP